Literature DB >> 9559873

Copper can promote oxidation of LDL by markedly different mechanisms.

O Ziouzenkova1, A Sevanian, P M Abuja, P Ramos, H Esterbauer.   

Abstract

Oxidation of LDL (0.1 microM) in PBS with copper concentrations ranging from 0.03 to 10 microM, equal to 0.3-100 Cu2+/LDL, was investigated by monitoring the formation of conjugated dienes at 234 nm. With all 8 LDL samples examined, the kinetics changed strongly at submicromolar Cu2+ concentrations. Based on time-course of the formation of conjugated dienes, cholesteryl linoleate hydroxides and hydroperoxides as well as the antioxidant consumption, two oxidation types were distinguished. Type A oxidations, observed at relatively high Cu2+ concentrations of 10-100 Cu2+/ LDL, represented the conventional kinetics of LDL oxidation with an inhibition period (= lag-time) followed by a propagation phase. In contrast, type C oxidations proceeded after a negligibly short lag time followed by a distinct propagation phase. The rate of this propagation increased rapidly to 0.5 mol diene/mol LDL and then slowed down in the presence of alpha-,gamma-tocopherols and carotenoids, which were consumed faster than tocopherols. The increase in diene absorption was due to the formation of both hydroxides and hydroperoxides suggesting a high initial decomposition of hydroperoxides. At submicromolar concentrations of about 0.1 to 0.5 microM, type C and type A oxidation can be combined resulting in 4 consecutive oxidation phases, i.e. 1st inhibition and 1st propagation (belonging to type C), followed by 2nd inhibition and 2nd propagation (belonging to type A). Increasing copper concentrations lowered the 1st propagation and shortened the 2nd inhibition periods until they melted into one apparent kinetic phase. Decreasing [Cu2+] increased the 1st propagation and 2nd inhibition but lowered the 2nd propagation phase until it completely disappeared. A threshold copper concentration, denoted as Cu(lim), can be calculated as a kinetic constant based on the Cu2+-dependence for the rate of 2nd propagation. Below Cu(lim), LDL oxidation proceeds only via type C kinetics. The Cu2+-dependence of the oxidation kinetics suggests that LDL contains two different Cu2+ biding sites. Cu2+ at the low-affinity binding sites, with half-saturation at 5-50 Cu2+/LDL, initiates and accelerates the 2nd propagation by decomposing lipid hydroperoxides. Cu2+ bound to the high-affinity binding sites, with half-saturation at 0.3-2.0 Cu2+/LDL, is responsible for the 1st propagation. Arguments in favor and against this propagation being due to tocopherol mediated peroxidation (TMP) are discussed. If the lag-time concept is extended to the conjugated diene curves seen for combined oxidation profiles, then a true inhibition phase does not apply to this time interval, but instead represents the time elapsed before the onset of the 2nd propagation phase.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9559873     DOI: 10.1016/s0891-5849(97)00324-9

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  10 in total

1.  Inhibition of LDL oxidation and oxidized LDL-induced cytotoxicity by dihydropyridine calcium antagonists.

Authors:  A Sevanian; L Shen; F Ursini
Journal:  Pharm Res       Date:  2000-08       Impact factor: 4.200

2.  When and why a water-soluble antioxidant becomes pro-oxidant during copper-induced low-density lipoprotein oxidation: a study using uric acid.

Authors:  M Bagnati; C Perugini; C Cau; R Bordone; E Albano; G Bellomo
Journal:  Biochem J       Date:  1999-05-15       Impact factor: 3.857

3.  Arterial endothelial dysfunction in baboons fed a high-cholesterol, high-fat diet.

Authors:  Qiang Shi; Jane F Vandeberg; Catherine Jett; Karen Rice; Michelle M Leland; Leslie Talley; Rampratap S Kushwaha; David L Rainwater; John L Vandeberg; Xing Li Wang
Journal:  Am J Clin Nutr       Date:  2005-10       Impact factor: 7.045

4.  Protection of mitochondria during cold storage of liver and following transplantation: comparison of the two solutions, University of Wisconsin and Eurocollins.

Authors:  Wayel Jassem; Tatiana Armeni; José L Quiles; Stefano Bompadre; Giovanni Principato; Maurizio Battino
Journal:  J Bioenerg Biomembr       Date:  2006-05-24       Impact factor: 2.945

5.  Thiol oxidase ability of copper ion is specifically retained upon chelation by aldose reductase.

Authors:  Francesco Balestri; Roberta Moschini; Mario Cappiello; Umberto Mura; Antonella Del-Corso
Journal:  J Biol Inorg Chem       Date:  2017-02-21       Impact factor: 3.358

6.  Absence of an effect of vitamin E on protein and lipid radical formation during lipoperoxidation of LDL by lipoxygenase.

Authors:  Douglas Ganini; Ronald P Mason
Journal:  Free Radic Biol Med       Date:  2014-08-01       Impact factor: 7.376

7.  Carbon monoxide promotes respiratory hemoproteins iron reduction using peroxides as electron donors.

Authors:  Elena A Sher; Mati Shaklai; Nurith Shaklai
Journal:  PLoS One       Date:  2012-03-12       Impact factor: 3.240

8.  Dapsone protects brain microvascular integrity from high-fat diet induced LDL oxidation.

Authors:  Rui Zhan; Mingming Zhao; Ting Zhou; Yue Chen; Weiwei Yu; Lei Zhao; Tao Zhang; Hecheng Wang; Huan Yang; Yinglan Jin; Qihua He; Xiaoda Yang; Xiangyang Guo; Belinda Willard; Bing Pan; Yining Huang; Yingyu Chen; Dehua Chui; Lemin Zheng
Journal:  Cell Death Dis       Date:  2018-06-07       Impact factor: 8.469

9.  Absence of clinical relationship between oxidized low density lipoproteins and diabetic peripheral neuropathy: a case control study.

Authors:  Alma Rosales-Hernandez; Audrey Cheung; Peter Podgorny; Cynthia Chan; Cory Toth
Journal:  Lipids Health Dis       Date:  2014-02-12       Impact factor: 3.876

10.  Ethyl pyruvate inhibits oxidation of LDL in vitro and attenuates oxLDL toxicity in EA.hy926 cells.

Authors:  Christine Rossmann; Christoph Nusshold; Margret Paar; Gerhard Ledinski; Erwin Tafeit; Martin Koestenberger; Eva Maria Bernhart; Wolfgang Sattler; Gerhard Cvirn; Seth Hallström
Journal:  PLoS One       Date:  2018-01-25       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.